Design, synthesis and identification of novel colchicine-derived immunosuppressant

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4416-20. doi: 10.1016/j.bmcl.2009.05.054. Epub 2009 May 18.

Abstract

Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoimmune Diseases / drug therapy
  • Chemistry, Pharmaceutical / methods
  • Colchicine / analogs & derivatives*
  • Colchicine / chemical synthesis
  • Colchicine / pharmacology
  • Cyclosporine / pharmacology
  • Drug Design
  • Gout Suppressants / chemical synthesis
  • Gout Suppressants / pharmacology
  • Graft Rejection
  • Humans
  • Immunosuppressive Agents / chemical synthesis*
  • Immunosuppressive Agents / pharmacology
  • Inflammation
  • Inhibitory Concentration 50
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Rats
  • Skin Transplantation
  • Structure-Activity Relationship

Substances

  • Gout Suppressants
  • Immunosuppressive Agents
  • Cyclosporine
  • Colchicine